Ubs Asset Management Americas Inc Ideaya Biosciences, Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 318,496 shares of IDYA stock, worth $8.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
318,496
Previous 312,277
1.99%
Holding current value
$8.01 Million
Previous $11 Million
7.98%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IDYA
# of Institutions
215Shares Held
80.8MCall Options Held
69KPut Options Held
20K-
Black Rock Inc. New York, NY6.81MShares$171 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.21MShares$131 Million0.38% of portfolio
-
Janus Henderson Group PLC London, X05.16MShares$130 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$121 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.02MShares$101 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.21B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...